• 文献检索
  • 文档翻译
  • 深度研究
  • 学术资讯
  • Suppr Zotero 插件Zotero 插件
  • 邀请有礼
  • 套餐&价格
  • 历史记录
应用&插件
Suppr Zotero 插件Zotero 插件浏览器插件Mac 客户端Windows 客户端微信小程序
定价
高级版会员购买积分包购买API积分包
服务
文献检索文档翻译深度研究API 文档MCP 服务
关于我们
关于 Suppr公司介绍联系我们用户协议隐私条款
关注我们

Suppr 超能文献

核心技术专利:CN118964589B侵权必究
粤ICP备2023148730 号-1Suppr @ 2026

文献检索

告别复杂PubMed语法,用中文像聊天一样搜索,搜遍4000万医学文献。AI智能推荐,让科研检索更轻松。

立即免费搜索

文件翻译

保留排版,准确专业,支持PDF/Word/PPT等文件格式,支持 12+语言互译。

免费翻译文档

深度研究

AI帮你快速写综述,25分钟生成高质量综述,智能提取关键信息,辅助科研写作。

立即免费体验

利用逆转录病毒插入诱变筛选鉴定具有致癌潜力的蛋白酪氨酸激酶。

Identification of protein tyrosine kinases with oncogenic potential using a retroviral insertion mutagenesis screen.

机构信息

Department of Molecular and Developmental Genetics, VIB, Leuven, Belgium.

出版信息

Haematologica. 2009 Oct;94(10):1440-4. doi: 10.3324/haematol.2009.007328.

DOI:10.3324/haematol.2009.007328
PMID:19794087
原文链接:https://pmc.ncbi.nlm.nih.gov/articles/PMC2754961/
Abstract

Protein tyrosine kinases form a large family of signaling proteins implicated in both normal and malignant cell signaling. The aim of this study was to identify protein tyro-sine kinases that can transform hematopoietic cells to growth factor independent proliferation when constitutively activated by homodimerization. We used a modified retroviral insertion mutagenesis screen with a retroviral vector containing the homodimerization domain of ETV6 followed by an artificial splice donor site. Integration of this retroviral vector within a gene of the host genome would generate a fusion transcript containing the dimerization domain and part of the disrupted gene. Using this strategy with the IL3 dependent Ba/F3 cell line, we identified 8 different protein tyrosine kinases (Abl1, Fgfr1, Hck, Jak2, Lck, Mertk, Mst1r, Tnk1) that transformed the cells. These results characterize HCK, MERTK, MST1R and TNK1 as potential oncogenes and describe a method to identify gain-of-function fusion genes using a retroviral insertion screen.

摘要

蛋白酪氨酸激酶形成了一个庞大的信号蛋白家族,涉及正常和恶性细胞信号。本研究的目的是鉴定蛋白酪氨酸激酶,当它们通过同源二聚化被持续激活时,能够将造血细胞转化为生长因子非依赖性增殖。我们使用了一种改良的逆转录病毒插入诱变筛选方法,使用包含 ETV6 同源二聚化结构域的逆转录病毒载体,随后是一个人工剪接供体位点。该逆转录病毒载体在宿主基因组内的基因中的整合将产生一个包含二聚化结构域和部分破坏基因的融合转录本。使用这种策略和 IL3 依赖性 Ba/F3 细胞系,我们鉴定出了 8 种不同的蛋白酪氨酸激酶(Abl1、Fgfr1、Hck、Jak2、Lck、Mertk、Mst1r、Tnk1),它们可以转化细胞。这些结果将 HCK、MERTK、MST1R 和 TNK1 表征为潜在的致癌基因,并描述了一种使用逆转录病毒插入筛选来鉴定获得功能融合基因的方法。

相似文献

1
Identification of protein tyrosine kinases with oncogenic potential using a retroviral insertion mutagenesis screen.利用逆转录病毒插入诱变筛选鉴定具有致癌潜力的蛋白酪氨酸激酶。
Haematologica. 2009 Oct;94(10):1440-4. doi: 10.3324/haematol.2009.007328.
2
Genetic screens in mammalian cells by enhanced retroviral mutagens.利用增强型逆转录病毒诱变剂对哺乳动物细胞进行遗传筛选。
Oncogene. 2000 Dec 7;19(52):5964-72. doi: 10.1038/sj.onc.1203992.
3
The Ras GTPase-activating protein (GAP) is an SH3 domain-binding protein and substrate for the Src-related tyrosine kinase, Hck.Ras GTP酶激活蛋白(GAP)是一种SH3结构域结合蛋白,也是Src相关酪氨酸激酶Hck的底物。
J Biol Chem. 1995 Jun 16;270(24):14718-24. doi: 10.1074/jbc.270.24.14718.
4
Retroviral insertional mutagenesis: past, present and future.逆转录病毒插入诱变:过去、现在与未来。
Oncogene. 2005 Nov 21;24(52):7656-72. doi: 10.1038/sj.onc.1209043.
5
Most of the substrates of oncogenic viral tyrosine protein kinases can be phosphorylated by cellular tyrosine protein kinases in normal cells.致癌病毒酪氨酸蛋白激酶的大多数底物在正常细胞中可被细胞酪氨酸蛋白激酶磷酸化。
Oncogene Res. 1988 Sep;3(2):105-15.
6
An epidermal growth factor receptor/Jak2 tyrosine kinase domain chimera induces tyrosine phosphorylation of Stat5 and transduces a growth signal in hematopoietic cells.一种表皮生长因子受体/ Jak2酪氨酸激酶结构域嵌合体可诱导Stat5的酪氨酸磷酸化,并在造血细胞中传导生长信号。
J Biol Chem. 1996 Aug 9;271(32):19483-8. doi: 10.1074/jbc.271.32.19483.
7
The ETV6-NTRK3 gene fusion encodes a chimeric protein tyrosine kinase that transforms NIH3T3 cells.ETV6-NTRK3基因融合编码一种嵌合蛋白酪氨酸激酶,可转化NIH3T3细胞。
Oncogene. 2000 Feb 17;19(7):906-15. doi: 10.1038/sj.onc.1203396.
8
Activation of the gene for the PDGF receptor beta1 (PDGFRbeta) in interleukin-3-dependent myeloid cells by retroviral insertional mutagenesis: implications for the transforming potential of PDGFRbeta.通过逆转录病毒插入诱变激活白细胞介素-3依赖性髓样细胞中血小板衍生生长因子受体β1(PDGFRβ)基因:对PDGFRβ转化潜能的影响
Growth Factors. 2002 Sep;20(3):131-40. doi: 10.1080/0897719021000058139.
9
Targeting PIM kinases impairs survival of hematopoietic cells transformed by kinase inhibitor-sensitive and kinase inhibitor-resistant forms of Fms-like tyrosine kinase 3 and BCR/ABL.靶向PIM激酶会损害由激酶抑制剂敏感型和激酶抑制剂耐药型Fms样酪氨酸激酶3及BCR/ABL转化的造血细胞的存活。
Cancer Res. 2006 Apr 1;66(7):3828-35. doi: 10.1158/0008-5472.CAN-05-2309.
10
Phosphorylation-dependent interactions between ADAM15 cytoplasmic domain and Src family protein-tyrosine kinases.ADAM15胞质结构域与Src家族蛋白酪氨酸激酶之间的磷酸化依赖性相互作用。
J Biol Chem. 2002 Feb 15;277(7):4999-5007. doi: 10.1074/jbc.M107430200. Epub 2001 Dec 10.

引用本文的文献

1
Recent advances in TAM mechanisms in lung diseases.肺部疾病中肿瘤相关巨噬细胞(TAM)机制的最新进展。
J Transl Med. 2025 Apr 26;23(1):479. doi: 10.1186/s12967-025-06398-2.
2
Differential regulatory effects of the N-terminal region in SYK-fusion kinases reveal unique activation-inducible nuclear translocation of ITK-SYK.SYK融合激酶中N端区域的差异调节作用揭示了ITK-SYK独特的激活诱导核转位。
Sci Rep. 2025 Jan 4;15(1):814. doi: 10.1038/s41598-024-83962-8.
3
Integrating Clinical Cancer and PTM Proteomics Data Identifies a Mechanism of ACK1 Kinase Activation.整合临床癌症和 PTM 蛋白质组学数据鉴定 ACK1 激酶激活的机制。
Mol Cancer Res. 2024 Feb 1;22(2):137-151. doi: 10.1158/1541-7786.MCR-23-0153.
4
Targeting MERTK and AXL in Mutant Non-Small Cell Lung Cancer.靶向突变型非小细胞肺癌中的MERTK和AXL
Cancers (Basel). 2021 Nov 11;13(22):5639. doi: 10.3390/cancers13225639.
5
TNK1 is a ubiquitin-binding and 14-3-3-regulated kinase that can be targeted to block tumor growth.TNK1 是一种泛素结合和 14-3-3 调节的激酶,可以作为靶点来阻断肿瘤生长。
Nat Commun. 2021 Sep 9;12(1):5337. doi: 10.1038/s41467-021-25622-3.
6
Fusion transcripts FYN-TRAF3IP2 and KHDRBS1-LCK hijack T cell receptor signaling in peripheral T-cell lymphoma, not otherwise specified.融合转录本 FYN-TRAF3IP2 和 KHDRBS1-LCK 劫持外周 T 细胞淋巴瘤、非特指型中的 T 细胞受体信号。
Nat Commun. 2021 Jun 17;12(1):3705. doi: 10.1038/s41467-021-24037-4.
7
Thirty-eight-negative kinase 1 mediates trauma-induced intestinal injury and multi-organ failure.三十八阴性激酶 1 介导创伤诱导的肠道损伤和多器官衰竭。
J Clin Invest. 2018 Nov 1;128(11):5056-5072. doi: 10.1172/JCI97912. Epub 2018 Oct 15.
8
Role of Growth arrest-specific gene 6-Mer axis in multiple myeloma.生长停滞特异性基因 6-Mer 轴在多发性骨髓瘤中的作用。
Leukemia. 2015 Mar;29(3):696-704. doi: 10.1038/leu.2014.236. Epub 2014 Aug 8.
9
Molecular pathways: MERTK signaling in cancer.分子通路:MERTK 信号通路与癌症。
Clin Cancer Res. 2013 Oct 1;19(19):5275-80. doi: 10.1158/1078-0432.CCR-12-1451. Epub 2013 Jul 5.
10
Drosophila activated Cdc42 kinase has an anti-apoptotic function.果蝇激活的 Cdc42 激酶具有抗细胞凋亡的功能。
PLoS Genet. 2012;8(5):e1002725. doi: 10.1371/journal.pgen.1002725. Epub 2012 May 17.

本文引用的文献

1
Identification of the transforming EML4-ALK fusion gene in non-small-cell lung cancer.非小细胞肺癌中转化型EML4-ALK融合基因的鉴定。
Nature. 2007 Aug 2;448(7153):561-6. doi: 10.1038/nature05945. Epub 2007 Jul 11.
2
Thirty-eight-negative kinase 1 (TNK1) facilitates TNFalpha-induced apoptosis by blocking NF-kappaB activation.38-负性激酶1(TNK1)通过阻断核因子κB(NF-κB)激活促进肿瘤坏死因子α(TNFα)诱导的细胞凋亡。
Oncogene. 2007 Oct 4;26(45):6536-45. doi: 10.1038/sj.onc.1210476. Epub 2007 Apr 30.
3
Retroviral DNA integration: viral and cellular determinants of target-site selection.逆转录病毒DNA整合:靶位点选择的病毒和细胞决定因素
PLoS Pathog. 2006 Jun;2(6):e60. doi: 10.1371/journal.ppat.0020060. Epub 2006 Jun 23.
4
Lymphoblastic leukemia/lymphoma in mice overexpressing the Mer (MerTK) receptor tyrosine kinase.过表达Mer(MerTK)受体酪氨酸激酶的小鼠中的淋巴细胞白血病/淋巴瘤
Oncogene. 2006 Oct 5;25(45):6092-100. doi: 10.1038/sj.onc.1209633. Epub 2006 May 1.
5
Tyrosine kinases as targets for cancer therapy.酪氨酸激酶作为癌症治疗的靶点。
N Engl J Med. 2005 Jul 14;353(2):172-87. doi: 10.1056/NEJMra044389.
6
RON, a tyrosine kinase receptor involved in tumor progression and metastasis.RON是一种参与肿瘤进展和转移的酪氨酸激酶受体。
Ann Surg Oncol. 2005 Apr;12(4):273-81. doi: 10.1245/ASO.2005.08.013. Epub 2005 Mar 15.
7
Prognostic significance of co-expression of RON and MET receptors in node-negative breast cancer patients.RON和MET受体共表达在淋巴结阴性乳腺癌患者中的预后意义
Clin Cancer Res. 2005 Mar 15;11(6):2222-8. doi: 10.1158/1078-0432.CCR-04-1761.
8
The C terminus of RON tyrosine kinase plays an autoinhibitory role.RON酪氨酸激酶的C末端发挥自抑制作用。
J Biol Chem. 2005 Mar 11;280(10):8893-900. doi: 10.1074/jbc.M412623200. Epub 2005 Jan 4.
9
Kos1, a nonreceptor tyrosine kinase that suppresses Ras signaling.Kos1,一种抑制Ras信号传导的非受体酪氨酸激酶。
Oncogene. 2003 Jun 5;22(23):3562-77. doi: 10.1038/sj.onc.1206480.
10
A tyrosine kinase created by fusion of the PDGFRA and FIP1L1 genes as a therapeutic target of imatinib in idiopathic hypereosinophilic syndrome.一种由血小板衍生生长因子受体A(PDGFRA)基因与FIP1L1基因融合产生的酪氨酸激酶,作为伊马替尼治疗特发性嗜酸性粒细胞增多综合征的靶点。
N Engl J Med. 2003 Mar 27;348(13):1201-14. doi: 10.1056/NEJMoa025217.